These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 1559303)
21. Inhibition of ovulation during discontinuous intranasal luteinizing hormone-releasing hormone agonist dosing in combination with gestagen-induced bleeding. Lemay A; Faure N; Labrie F; Fazekas AT Fertil Steril; 1985 Jun; 43(6):868-77. PubMed ID: 3158551 [TBL] [Abstract][Full Text] [Related]
22. The effect of ovarian arterial infusion of transforming growth factor alpha on ovarian follicle populations and ovarian hormone secretion in ewes with an autotransplanted ovary. Campbell BK; Gordon BM; Scaramuzzi RJ J Endocrinol; 1994 Oct; 143(1):13-24. PubMed ID: 7964312 [TBL] [Abstract][Full Text] [Related]
23. The effect of a potent gonadotrophin-releasing hormone antagonist on ovarian secretion of oestradiol, inhibin and androstenedione and the concentration of LH and FSH during the follicular phase of the sheep oestrous cycle. Campbell BK; McNeilly AS; Picton HM; Baird DT J Endocrinol; 1990 Sep; 126(3):377-84. PubMed ID: 2120381 [TBL] [Abstract][Full Text] [Related]
24. Triggering of ovulation in human menopausal gonadotrophin-stimulated cycles: comparison between intravenously administered gonadotrophin-releasing hormone (100 and 500 micrograms), GnRH agonist (buserelin, 500 micrograms) and human chorionic gonadotrophin (10,000 IU). Gerris J; De Vits A; Joostens M; Van Royen E Hum Reprod; 1995 Jan; 10(1):56-62. PubMed ID: 7745071 [TBL] [Abstract][Full Text] [Related]
25. Measurement of inhibin-A (alpha beta A dimer) during the oestrous cycle, after manipulation of ovarian activity and during pregnancy in ewes. Knight PG; Feist SA; Tannetta DS; Bleach EC; Fowler PA; O'Brien M; Groome NP J Reprod Fertil; 1998 May; 113(1):159-66. PubMed ID: 9713389 [TBL] [Abstract][Full Text] [Related]
26. Purified FSH stimulates production of inhibin by the human ovary. Buckler HM; Healy DL; Burger HG J Endocrinol; 1989 Jul; 122(1):279-85. PubMed ID: 2504869 [TBL] [Abstract][Full Text] [Related]
27. Age related changes in follicle stimulating hormone, luteinizing hormone, oestradiol and immunoreactive inhibin in women of reproductive age. MacNaughton J; Banah M; McCloud P; Hee J; Burger H Clin Endocrinol (Oxf); 1992 Apr; 36(4):339-45. PubMed ID: 1424166 [TBL] [Abstract][Full Text] [Related]
28. Suppression of ovarian activity by Zoladex depot (ICI 118630), a long-acting luteinizing hormone releasing hormone agonist analogue. West CP; Baird DT Clin Endocrinol (Oxf); 1987 Feb; 26(2):213-20. PubMed ID: 2959405 [TBL] [Abstract][Full Text] [Related]
29. Changes in gonadotrophin response to gonadotrophin releasing hormone in normal women following bilateral ovariectomy. Alexandris E; Milingos S; Kollios G; Seferiadis K; Lolis D; Messinis IE Clin Endocrinol (Oxf); 1997 Dec; 47(6):721-6. PubMed ID: 9497880 [TBL] [Abstract][Full Text] [Related]
30. The effects of continuous treatment of stallions with high levels of a potent GnRH analogue. Boyle MS; Skidmore J; Zhang J; Cox JE J Reprod Fertil Suppl; 1991; 44():169-82. PubMed ID: 1795259 [TBL] [Abstract][Full Text] [Related]
31. FSH causes a time-dependent stimulation of preovulatory follicle growth in the absence of pulsatile LH secretion in ewes chronically treated with gonadotrophin-releasing hormone agonist. Picton HM; Tsonis CG; McNeilly AS J Endocrinol; 1990 Aug; 126(2):297-307. PubMed ID: 2119415 [TBL] [Abstract][Full Text] [Related]
32. Gonadotropin, steroid, and inhibin levels in women with incipient ovarian failure during anovulatory and ovulatory rebound cycles. Buckler HM; Evans CA; Mamtora H; Burger HG; Anderson DC J Clin Endocrinol Metab; 1991 Jan; 72(1):116-24. PubMed ID: 1824706 [TBL] [Abstract][Full Text] [Related]
34. Regulation of expression of ovarian mRNA encoding steroidogenic enzymes and gonadotrophin receptors by FSH and GH in hypogonadotrophic cattle. Garverick HA; Baxter G; Gong J; Armstrong DG; Campbell BK; Gutierrez CG; Webb R Reproduction; 2002 May; 123(5):651-61. PubMed ID: 12006093 [TBL] [Abstract][Full Text] [Related]
35. [Continuous subcutaneous infusion of GnRH agonist: effective dosage in the treatment of endometriosis and its influence on the ovarian response to human menopausal gonadotropin]. Masaoka K; Kitazawa M; Watanabe H; Kumasaka T Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jun; 41(6):729-36. PubMed ID: 2504848 [TBL] [Abstract][Full Text] [Related]
36. Fourteen-day versus twenty-one-day regimens of intermittent intranasal luteinizing hormone-releasing hormone agonist combined with an oral progestogen as antiovulatory contraceptive approach. Lemay A; Faure N J Clin Endocrinol Metab; 1986 Dec; 63(6):1379-85. PubMed ID: 2946711 [TBL] [Abstract][Full Text] [Related]
37. Controlled release of a GnRH agonist from a polyhydroxybutyric acid implant: reversible suppression of the menstrual cycle in the macaque. Fraser HM; Sandow J; Seidel HR; Lunn SF Acta Endocrinol (Copenh); 1989 Dec; 121(6):841-8. PubMed ID: 2514544 [TBL] [Abstract][Full Text] [Related]
38. Effect of steroid- and inhibin-free ovine follicular fluid on ovarian follicles and ovarian hormone secretion. Campbell BK; Picton HM; Mann GE; McNeilly AS; Baird DT J Reprod Fertil; 1991 Sep; 93(1):81-96. PubMed ID: 1920301 [TBL] [Abstract][Full Text] [Related]